Novartis Aktie
79,93
EUR
+0,24
EUR
+0,30
%
79,15
CHF
-0,39
CHF
-0,49
%
Novartis Aktie Analyse
02.02.23 | Novartis Underperform | Credit Suisse Group | |
02.02.23 | Novartis Sell | Deutsche Bank AG | |
25.01.23 | Novartis Underweight | Barclays Capital | |
06.01.23 | Novartis Underperform | Credit Suisse Group | |
06.01.23 | Novartis Underweight | Morgan Stanley | |
23.12.22 | Novartis Underweight | Barclays Capital | |
09.12.22 | Novartis Sell | Deutsche Bank AG | |
07.12.22 | Novartis Sell | Deutsche Bank AG | |
Werbung
|
|||
22.11.22 | Novartis Sell | Deutsche Bank AG | |
27.10.22 | Novartis Sell | Deutsche Bank AG | |
26.10.22 | Novartis Underperform | Credit Suisse Group | |
26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.22 | Novartis Underweight | Barclays Capital | |
25.10.22 | Novartis Sell | Deutsche Bank AG | |
14.10.22 | Novartis Underweight | Barclays Capital | |
07.10.22 | Novartis Sell | Deutsche Bank AG | |
23.09.22 | Novartis Sell | Deutsche Bank AG | |
23.09.22 | Novartis Underweight | Barclays Capital | |
23.09.22 | Novartis Underperform | Credit Suisse Group | |
21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
21.09.22 | Novartis Sell | Deutsche Bank AG | |
16.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
15.09.22 | Novartis Underperform | Credit Suisse Group | |
12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
20.07.22 | Novartis Sell | Deutsche Bank AG | |
19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
18.07.22 | Novartis Underweight | Barclays Capital | |
15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
29.06.22 | Novartis Sell | Deutsche Bank AG | |
22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
22.06.22 | Novartis Sell | Deutsche Bank AG | |
27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.22 | Novartis Sell | Deutsche Bank AG | |
26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
22.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
05.04.22 | Novartis Sell | Deutsche Bank AG | |
04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
03.02.22 | Novartis Sell | Deutsche Bank AG | |
02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
02.02.22 | Novartis Underweight | Barclays Capital | |
01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | Barclays Capital | |
20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
12.01.22 | Novartis Underweight | JP Morgan Chase & Co. |